Business Wire

CA-SKYLOOM

6.9.2022 09:01:47 CEST | Business Wire | Press release

Share
Space Compass and Skyloom Sign a Term Sheet to Bring Optical Data Relay Services to the Earth Observation Market

Skyloom and Space Compass (a newly formed joint venture between NTT and SKY Perfect JSAT) today announced that the companies signed a term sheet aimed to launch the first geostationary-based (GEO) data relay service over Asia that will leverage Skyloom’s cutting-edge communication and networking systems for the purpose of serving the rapidly growing Earth-Observation (EO) market for real-time, high-capacity, direct-to-cloud data transfer. The companies plan to deploy the first network infrastructure node over Asia in 2024 and anticipate expanding the GEO constellation to provide additional capacity and global coverage by 2026.

Global EO providers are rapidly expanding their constellations, thus creating immense amounts of data, typically in low-earth-orbit (LEO). The Compass-Skyloom system will provide an avenue for immediate, cost-effective transfer of EO data via GEO satellite direct to cloud so that their customers and end-users can leverage perishable information on a real-time basis. The system will rely on optical/laser communications terminals, enabling fibreless optical communications at the speed of business. The partnership combines the space heritage and operations experience of SKY Perfect JSAT, the telecommunications prowess of NTT, and the cutting-edge innovation of Skyloom to unveil both a joint architecture and service for the EO market.

"This new team, leveraging the state-of-the-art telecom technology and infrastructure solutions of Skyloom, will enable us to jointly deliver best-in-class service to our earth observation customers,” said Koichiro Matsufuji, Co-CEO, Space Compass.

“Skyloom is thrilled to be joining forces with Space Compass – which draws on the strengths of two market leaders in space operations and telecommunications. Together we look forward to providing groundbreaking data transport capabilities to the earth observation market, and this is only the beginning of what’s to come,” said Marcos Franceschini, Founder & CEO, Skyloom Global.

"By this partnership, we are excited to be able to provide ultra high-speed and real time data relay in a very economical manner for our customers as a first step toward a larger non-terrestrial network. We believe optical data relay technology is a keystone to innovate networking and computing in orbit between GEO, LEO and ground,” added Shigehiro Hori, Co-CEO, Space Compass.

About Space Compass Corporation

Space Compass is a joint venture company between NTT, Japanese ICT giant, and SKY Perfect JSAT Corporation, Asia’s largest satellite operator. We will launch a Space Integrated Computing Network to aid the realization of a sustainable society. For more information, visit our corporate website, space-compass.com.

About Skyloom Global Corporation

Skyloom is an Oakland, CA-based telecommunications innovator founded with the mission to develop, deploy, and operate one of the fundamental pieces of tomorrow's space communication infrastructure for the provision of data transport services on a planetary scale. They leverage deep heritage in space optical communications to enable real time data transfer so that customers and decisionmakers can leverage perishable information. www.skyloom.co

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220906005414/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Thales Builds Cryptographic Security for the Age of AI and Post-Quantum Computing14.9.2026 09:00:00 CEST | Press release

Thales launches Luna 8, a new hardware security module (HSM) to provide future-ready, quantum resistant security to protect critical data and applications Powered by a Thales designed cryptographic processor, it delivers unparalleled performance, enhanced protection and the flexibility to adapt to new security needs Drawing on decades of cryptographic expertise, Luna 8 combines trusted security with support for emerging technologies, including post quantum cryptography According to the 2026 Thales Data Threat Report, the threat of Harvest Now, Decrypt Later (HNDL) attacks was the top-cited risk, with 59% of organizations reporting that they are prototyping and evaluating post-quantum cryptography (PQC) algorithms to prepare for the quantum era. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260804748922/en/ ©Thales To help organizations turn this readiness into deployment,Thales, a global leader in advanced technologies, tod

U.S. FDA Accepts New Drug Application Under Priority Review for Takeda’s Zasocitinib in Moderate-to-Severe Plaque Psoriasis, with Potential to Redefine Oral Treatment Expectations14.9.2026 09:00:00 CEST | Press release

Acceptance is based on pivotal Phase 3 data demonstrating rapid, durable and consistent skin clearance, including in high-impact sites, in a convenient once-daily pill Results from nearly 3,000 patients support potential for next-generation TYK2 inhibitor to redefine oral treatment expectations in psoriasis The Prescription Drug User Fee Act (PDUFA) target action date is in the first quarter of calendar year 2027 Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) accepted its New Drug Application (NDA) under Priority Review for zasocitinib (TAK-279) for the treatment of adults with moderate-to-severe plaque psoriasis. Zasocitinib is an investigational, next-generation, highly selective and potent oral tyrosine kinase 2 (TYK2) inhibitor, which demonstrated rapid, durable and consistent skin clearance in Phase 3 plaque psoriasis studies.1-3 Addressing unmet needs in psoriasis treatment “Despite progress in psoriasis care, there remains a need for highly

SWISSto12 and Mitsubishi Electric Corporation Announce Strategic Partnership14.9.2026 09:00:00 CEST | Press release

The Memorandum of Understanding (MoU) and additional contract signal a new phase of collaboration on market development in the Asia Pacific (APAC) region SWISSto12 today announced a memorandum of understanding (MoU) with Mitsubishi Electric Corporation (MELCO) (TOKYO: 6503) to pursue joint opportunities on advanced payloads, radio frequency (RF) products, and market development in Japan and the APAC region. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260914982179/en/ Masahiko Arai, Executive Officer and Group President, Defense & Space Systems, Mitsubishi Electric, and Dr. Emile de Rijk, Chief Executive Officer, SWISSto12 Joint opportunities will leverage MELCO’s extensive satellite system expertise and integration capabilities together with SWISSto12’s proprietary 3D-printing designs and processes that form the foundation of its next-generation payloads—smaller, lighter, highly performant, yet built in materially shorter

Focused Support Launches Cavok STRIKE to Expand Link-16 Participation Across the Joint Force14.9.2026 07:00:00 CEST | Press release

Extending Link-16 interoperability without platform-level hardware integration Focused Support LLC today announced the launch of Cavok STRIKE, an integrated software capability that expands the Link-16 tactical battlespace picture by enabling additional operational platforms to participate in the Link-16 network. Modern battlefields have increasing numbers of unmanned systems, sensors, and supporting platforms operating throughout the joint battlespace. The rapid proliferation of Group 1, 2, and 3 UAS, including both expendable and recoverable systems, has created a growing need to integrate these assets into the broader tactical network. Many of these platforms provide operationally relevant information but have historically remained outside the Link-16 network due to limitations in size, weight, power, platform integration complexity, or acquisition cost. Cavok STRIKE addresses this gap by enabling platforms to participate in the Link-16 network as non-command-and-control participant

Fujirebio Expands Access to Blood-based Neurology Testing in Brazil with ANVISA Market Authorization for Lumipulse® G NfL Blood and Lumipulse G pTau 217 Plasma14.9.2026 07:00:00 CEST | Press release

H.U. Group Holdings Inc. and its wholly owned subsidiary Fujirebio today announced that the Brazilian Health Regulatory Agency (ANVISA) has granted market authorization for the Lumipulse G NfL Blood and Lumipulse G pTau 217 Plasma assays for use on the fully automated LUMIPULSE® G immunoassay platform in Brazil. “ANVISA authorization of the Lumipulse G NfL Blood and Lumipulse G pTau 217 Plasma assays marks another important step in our mission to expand access to reliable, clinically meaningful blood-based biomarkers for clinicians and patients worldwide,” said Christiaan De Wilde, CEO of Fujirebio Europe N.V. “By making both neurological biomarker assays available to laboratories on a single, fully automated platform, we are helping support more informed clinical decision-making across a broad range of neurological conditions and throughout the diagnostic pathway.” The Brazilian ANVISA authorizations are based on the already CE marked in vitro diagnostics (IVD) approvals of these two

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye